Drug Research
Priority Review of Lynparza If Paired With Abiraterone In US
Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to treat elderly patients with advanced castration-resistant prostate cancer (mCRPC).
AstraZeneca and MSD, also known as Merck...
News
Healthcare Benefits of Using Turmeric
It’s not surprising that turmeric has become one of the most common pantry staples and popular supplements. After all, not only does the spice add an incredible flavor to specific dishes, but it also possesses properties that can potentially...
Drug Research
Trends of Genuv Cancer Drug Show Potential For Alzheimers
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective impact on Alzheimer's disease, according to Genuv Inc. of South Korea, which has announced the...
Drug Research
Axsome Pitches Auvelity As A Depression Med Game-Changer
It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with MDD diagnoses and the unmet demand.
In light of this, the time is right for the...
News
As Vaccine Firms Prep For A Busy Season, Influenza May Hit
Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading vaccine developers are preparing to help fight it, even if the majority of the population...
Drug Research
Gene Therapy By Bluebird Bio Costing $2.8M Given Nod By FDA
Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US.
Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was authorised by the FDA on August 17, two days before the FDA's scheduled approval action...
Drug Research
ADCs Built On Starpharma Delivery Tech To Be Tested By Merck
As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will allow it to assess potential candidates using a dendrimer drug delivery technology.
Merck and Starpharma agreed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.